ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,595Medicare Part D Prescriptions Filled, Including Refills

Rank: 1077 out of 3593

$339K Total Retail Price of All Prescriptions

Rank: 1200 out of 3593

364 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
5% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 364 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 364 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 6,025 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
ATORVASTATIN CALCIUM 307 276 1 15
AMLODIPINE BESYLATE 296 278 2 3
HYDROCHLOROTHIAZIDE 214 210 3 10
LEVOTHYROXINE SODIUM 195 195 4 4
LOSARTAN-HYDROCHLOROTHIAZIDE 187 166 5 48
SIMVASTATIN 186 177 6 1
PANTOPRAZOLE SODIUM 178 171 7 45
LISINOPRIL 150 128 8 2
FUROSEMIDE 144 135 9 9
LOVASTATIN 125 121 10 20
METFORMIN HCL 124 112 11 6
LOSARTAN POTASSIUM 124 119 11 14
PRAVASTATIN SODIUM 122 122 13 13
WARFARIN SODIUM 119 119 14 18
GLIMEPIRIDE 118 99 15 44
RAMIPRIL 116 111 16 92
METOPROLOL SUCCINATE 110 110 17 19
TRAMADOL HCL 109 100 18 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 92 19 26
POTASSIUM CHLORIDE 101 89 20 24
ATENOLOL 100 96 21 11
SERTRALINE HCL 98 88 22 28
ALLOPURINOL 98 98 22 35
FLUTICASONE PROPIONATE 81 78 24 32
TAMSULOSIN HCL 74 74 25 33
RANITIDINE HCL 71 59 26 27
NEXIUM 69 69 27 36
NIFEDIPINE ER 67 67 28 75
CHLORTHALIDONE 66 66 29 227
JANUVIA 66 64 29 81
GABAPENTIN 62 35 31 16
LANTUS 58 34 32 57
OMEPRAZOLE 56 52 33 5
AMLODIPINE BESYLATE-BENAZEPRIL 53 53 34 65
ZOLPIDEM TARTRATE 53 50 34 12
GLYBURIDE-METFORMIN HCL 52 37 R 36 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.